Search results
Results from the WOW.Com Content Network
Chronic bronchitis is a type of chronic obstructive pulmonary disease, or COPD, that's defined by clinical symptoms like a productive cough for at least 3 weeks per year for at least 2 years. This video discusses the pathophysiology, clinical signs and symptoms, and treatment of chronic bronchitis.
First-line treatment is cefuroxime or co-amoxiclav. [7] Third-line treatment, as well as treatment in penicillin-allergic patients, is a fluoroquinolone such as ciprofloxacin. [7] An agent active against Streptococcus pneumoniae may have to be added. [7] Corticosteroids such as prednisolone reduce inflammation in the airways. [17]
Bronchitis. Acute bronchitis, also known as a chest cold, is a short-term inflammation of the bronchi of the lungs. [4] [6] The most common symptom is a cough that may or may not produce sputum.
Additionally, bronchitis is described as either acute or chronic depending on its presentation and is also further described by the causative agent. Acute bronchitis can be defined as acute bacterial or viral infection of the larger airways in healthy patients with no history of recurrent disease. [ 8 ]
Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by chronic respiratory symptoms and airflow limitation. [8] GOLD 2024 defined COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea or shortness of breath, cough, sputum production or exacerbations) due to abnormalities of the airways (bronchitis ...
Carbocisteine, also called carbocysteine, is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily.
Bronchodilators may be originating naturally within the body, or they may be medications administered for the treatment of breathing difficulties, usually in the form of inhalers. They are most useful in obstructive lung diseases , of which asthma and chronic obstructive pulmonary disease are the most common conditions.
The Buteyko method emphasizes the role of carbon dioxide and hyperventilation in respiratory diseases as well as overall health. It is known that hyperventilation can lead to low carbon dioxide levels in the blood (or hypocapnea), which can subsequently lead to disturbances of the acid-base balance in the blood and lower tissue oxygen levels.